Vivo Bio Tech
VIVOBIOTEC · Pharma > Pharmaceuticals & Drugs Listing date: Sept. 25, 2012

Stock Price vs Company Growth
1d
1.3%
1w
12.4%
1m
6.3%
3m
0.1%
6m
8.3%
1y
17.1%
5y
3.4%
10y
8.3%
all
11.2%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 38.6 1.3%
31.2
43
Company Overview

Sales
46.8 Cr
Growth: -10.7%
Profit after Tax
7.46 Cr
Growth: 192.4%
Micro Cap
57.5 Cr
P/E: 8.0x
Industry P/E: 36.0x
Fundamentals

Sales (Cr) ₹ 46.8
Growth -10.7%
EBITDA 46.4%
P/S 1.2x
Dividend 0.0%
P/E 8.0x
Book Value ₹ 40.1
PEG Ratio -0.7x
ROE 13.4%
P/B 1.0x
Shareholding Pattern

Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed

Vivo Bio Tech was incorporated on February 12, 1987 as Golden Growth Fund, Hyderabad-based Vivo Bio Tech (VBTL) is a contract research company engaged in biotechnology and pharma drug discovery activities. The company was converted into a public limited company from Jun. 19, 1992. VBTL provides services ranging from insilico design, wet lab contract research, preclinical research and clinical studies spanning the entire drug discovery value chain.
Investors (3)